Simplex Trading
TNXP icon

Simplex Trading’s Tonix Pharmaceuticals TNXP Stock Holding History

Simplex Trading’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
22,900
+14,000
+157% +$181K ﹤0.01% 4255
2026
Q1 		$122K Buy
+8,900
New +$137K ﹤0.01% 4850
2025
Q4 		– Sell
-2,800
Closed -$67K – 10084
2025
Q3 		$67K Buy
+2,800
New +$104K ﹤0.01% 6157
2016
Q1 		– Hold
0
– -$4K – 6250
2015
Q4 		– Hold
0
– – – 4072
2015
Q3 		– Hold
0
– -$8K – 6200
2015
Q2 		– Hold
0
– – – 3280
2015
Q1 		– Hold
0
– – – 3250

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's TNXP Position: Q2 2026 in Review

Simplex Trading sold out of Tonix Pharmaceuticals (TNXP) in Q2 2026, closing a stake of 5,108 shares — an estimated $65.9K sold.

Simplex Trading first reported a position in TNXP in Q1 2026 and held it in 1 quarter. The position peaked at $70.2K in Q1 2026. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Simplex Trading reported no remaining Tonix Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 5,108 Tonix Pharmaceuticals shares in Q2 2026, an estimated $65.9K.
  • Simplex Trading first reported a position in Tonix Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Simplex Trading's Tonix Pharmaceuticals position peaked at $70.2K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.